Skip to content

Long-Term Outcomes of Multidisciplinary Care versus Usual care in post-severe acute kidney injury survivors.

Long-Term Outcomes of Multidisciplinary Care versus Usual care in post-severe acute kidney injury survivors.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
TCTR
Registry ID
TCTR20250418001
Enrollment
294
Registered
2025-04-18
Start date
2025-04-17
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rate of recurrent acute kidney injury (AKI) in post-severe acute kidney injury survivors. acute kidney injury, Multidisciplinary care

Interventions

1. Nephrologist is the primary physician responsible for coordinating with other members to manage post-AKI transitional care, such as preventing kidney degeneration, preparing renal replacement thera
Prevention,Prevention
multidisciplinary care,usual care

Sponsors

None listed

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: Survivors of acute kidney injury stage 2 and 3 using the criteria according to the KDIGO criteria 2012 who are admitted to Thammasat University Hospital.

Exclusion criteria

Exclusion criteria: 1. Volunteers with End Stage Kidney Disease (ESKD) who have received kidney replacement therapy whether it is peritoneal dialysis or hemodialysis 2. Volunteers with CKD-EPI equation 2021 estimated glomerular filtration rate less than 15 ml/min/1.73m2 3. Volunteers who received kidney transplants. 4. Volunteers with very severe illness and expected to die within 12 months from untreatable or uncontrolled underlying diseases such as end stage liver or heart disease, uncurable malignancy. 5. Volunteers who cannot come to the hospital for follow-up

Design outcomes

Primary

MeasureTime frame
Rate of recurrent acute kidney injury (AKI) 1 year creatinine

Secondary

MeasureTime frame
MAKE (Major adverse kidney events) 1 year Presence of kidney replacement therapy, persistent kidney dysfunction, and death,MACE (Major adverse cardiac events) 1 year Presence of myocardial infarction, stroke, heart failure, atrial fibrillation, cardiovascular death,Readmission rate 1 year Physician reported outcome,incidence of type 2 diabetes mellitus 1 year Physician reported outcome,incidence of hypertension 1 year Physician reported outcome,incidence of fracture 1 year Physician reported outcome,incidence of malignancy 1 year Physician reported outcome

Countries

Thailand

Contacts

Public ContactPatharasit Jindapateep

Thammasat university hospital

patjin2@tu.ac.th029269794

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 10, 2026